Age- and disease-related innate immunity of human leukocytes ex vivo

Experimental Gerontology

Volumn 47, Issue 1, 2012, Pages 8-13

  Jatczak, Bogna ^a   Leszek, Jerzy ^b   Siemieniec, Iwona ^a   Sochocka, Marta ^a   Wiśniewska, Agnieszka ^a   Tarkowski, Radosław ^b   Bebenek, Marek ^c   Błach Olszewska, Zofia ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

Author keywords

Alzheimer's disease; Antiviral human leukocyte resistance; Cancer disease; Cytokine production; Human age

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIGESTIVE SYSTEM CANCER; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; INNATE IMMUNITY; LEUKOCYTE; MALE; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS IMMUNITY; VIRUS REPLICATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYTOKINES; DIGESTIVE SYSTEM NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RHABDOVIRIDAE INFECTIONS; YOUNG ADULT;

VESICULAR STOMATITIS VIRUS;

EID: 84155164871     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.09.010     Document Type: Article

References (24)

1. Baccala R., Kono D.H. Interferons as pathogenic effectors in autoimmunity. Immunol. Rev. 2005, 204:9-26.
2. Bali S., Kar S.S., Kumar S., Ratho R.K., Dhimar R.K., Kumar R. Hepatitis E epidemic in town of north India. Indian J. Public Health 2008, 52:189-193.
3. Błach-Olszewska Z. Innate immunity; cells, receptors, and signaling pathways. Arch. Immunol. Ther. Exp. 2005, 53:245-253.
4. Candore G., Caruso C., Jirillo E., Magnore T., Vasto S. Low grade inflammation as a common pathogenic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr. Pharm. Des. 2010, 16:584-596.
5. Carroll M.L., Yerkovich S.T., Pritchard A.L., Davies J.M., Upham J.W. Adaptive immunity to rhinoviruses: sex and age matter. Respir. Res. 2010, 11:184.
6. Fang M., Roscoe F., Sigal L.J. Age-dependent susceptibility to viral disease due to decreased natural killer cell numbers and trafficking. J. Exp Med. 2010, 207:2369-2381.
7. Giunta S. Is inflammaging an auto [innate] immunity subclinical syndrome?. Immun. Ageing 2006, 16:3-12.
8. Janeisins M.C., Mastranglo M.A., Park K.M., Sudol K.L., Narrow W.C., Oddo S., LaFerla F.M., Callahan L.M., Federoff H.J., Bowers W.J. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neural death in 3xTg-AD mice. Am. J. Pathol. 2008, 173:1768-1782.
9. Kong K.F., Delroux K., Wang X., Qian F., Arjona A., Malavista S.E., Fikring E., Montgomery R.R. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 2008, 82:7613-7623.
10. Maletzki C., Emmerich J. Inflammation and immunity in the tumor environment. Dig. Dis. 2010, 28:574-578.
11. Orzechowska B., Antoszków Z., Błach-Olszewska Z. Individual differentiation of innate antiviral immunity in humans; the role endogenous interferons and tumor necrosis factor in the immunity of leukocytes. Arch. Immunol. Ther. Exp. 2003, 51:51-60.
12. Orzechowska B., Antoszków Z., Siemieniec I., Lorenc M., Jatczak B., Błach-Olszewska Z. Cytokine production by human leukocytes with different expression of natural antiviral immunity and the effect of antibodies against interferons and TNFα. Arch. Immunol. Ther. Exp. 2007, 55:111-117.
13. Paradowska E., Błach-Olszewska Z., Sender J., Jarosz W. Antiviral nonspecific immunity of human placenta at term; possible role of endogenous tumor necrosis factors and interferons. J. Interferon Cytokine Res. 1996, 16:941-948.
14. Poea-Guyon S., Christados P., LePanse R., Guyon T., DeBaets M., Bidault J., Tzartos S., Berrih-Aknin S. Effects of cytokines on acetylocholine receptor expression: implication for myasthenia gravis. J. Immunol. 2005, 174:5941-5949.
15. Pawelec G., Derhovanessian E., Larbi A., Stinhall J., Wikby A. Cytomegalovirus and human senescence. Rev. Med. Virol. 2009, 19:47-56.
16. Rybka K., Orzechowska B., Siemieniec I., Leszek J., Zaczyńska E., Pajók J., Błach-Olszewska Z. Age related natural antiviral non-specific immunity of human leukocytes. Med. Sci. Monit. 2003, 9:413-419. BR.
17. Saha R.N., Gosh A., Palecia C.A., Fung Y.K., Dudek S.M., Pahan K. TNF-alpha preconditioning protect neurons via neuron-specific up-regulation of CREB-binding protein. J. Immunol. 2009, 183:2068-2078.
18. Saneto H., Kobayashi M., Kawamura Y., Yatsuji H., Sezaki H., Hosaka T., Acuta N., Suzuki F., Suzuki Y., Arase Y., Ikeda K., Kumada H. Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients. J. Gastroenterol. 2008, 43:975-981.
19. Solana R., Pawelec G., Tarazona R. Aging and innate immunity. Immunity 2006, 24:491-494.
20. Saltykova T.S. Influenza morbidity and mortality from cardiovascular and respiratory diseases in elderly patients. Ter. Arkh. 2008, 80:40-44.
21. Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr. Opin. Immunol. 2010, 22:507-513.
22. Zaczyńska E., Broniarek E., Błach-Olszewska Z. Spontaneous and lipopolysaccharide-induced tumor necrosis factor alpha and interferon beta production by resident peritoneal cells of mice: effect of sex, age, and strain. Arch. Immunol. Ther. Exp. 1993, 41:67-71.
23. Zaczyńska E., DuŚ D., Paprocka M., Błach-Olszewska Z. Resistance of human leukocytes to vesicular stomatitis virus infection as one of the innate antiviral immune activities; participation of cell subpopulations. Folia Histochim. Cytobiol. 2008, 46:39-43.
24. Zaczyńska E., Błach-Olszewska Z., Gejdel E. Production of cytokines with antiviral activity by endothelial cells. J. Interferon Cytokines Res. 1995, 15:811-814.